Author name: Anupriya Dhonchak

SpicyIP Weekly Review (March 29 – April 4)

/ By / Copyright, Drug Regulation, Innovation, Patent, Trademark

Topical Highlight Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research) In Part II of this post, Anupriya and Swaraj analyse the broader issue of IP ownership in outcomes of publicly funded research. They note that the government’s retention of IPR in Covaxin and the novel mRNA vaccine in the pipeline, would enable it to be in a position to share them with the rest of the developing world. They examine the patchwork of rules, […]

SpicyIP Weekly Review (March 29 – April 4) Read More »

Intellectual Property Rights in Covaxin – Part 3 (IP Rights over Clinical Drug Trials (CT) Data)

/ By / COVID-19, Data Exclusivity, Drug Regulation, Innovation, Patent, Trade Secret

In Part I of this post, Anik and I argued that the government should waive the IPR in Covaxin in order to ensure that the vaccine can be rapidly accessed by the public. In Part II of this post, Swaraj and I explored the broader issue of IP ownership in outcomes of publicly funded research. In Part III, I analyse the opacity surrounding the clinical trial data generated during the Covaxin trial, which has not been publicly shared on grounds

Intellectual Property Rights in Covaxin – Part 3 (IP Rights over Clinical Drug Trials (CT) Data) Read More »

Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research)

/ By / COVID-19, Drug Regulation, Others, Overlaps in IP, Patent, Trade Secret

This post was coauthored by Swaraj Paul Barooah and myself. In part I of this post, Anik and I argued that the government should waive the IPR in Covaxin in order to ensure that the vaccine can be rapidly accessed by the public. In Part II of this post, Swaraj and I analyse the broader issue of IP ownership in outcomes of publicly funded research. Part III explores opacity surrounding the clinical trial data generated during the Covaxin trial, which

Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research) Read More »

Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs)

/ By / COVID-19, Drug Regulation, Patent

(This post has been co-authored by Anik Bhaduri and myself. Anik is a fourth year student at NALSAR University of Law, Hyderabad.) A recent piece in the Economic Times argued that the Indian government should buy out the intellectual property rights to Covaxin, to bolster the commitment to its WTO proposal along with South Africa, to waive all IPRs on patents, copyright, industrial design and undisclosed information pertaining to vaccines for Covid-19 (covered previously on the blog here, here and

Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs) Read More »

Sherlyn Chopra Case: Non-Consensual Sharing of Intimate Images/Videos, Obscenity Laws and Copyright Remedies

/ By / Copyright, Privacy

Factual Background The Bombay High Court recently granted interim anticipatory bail to actor and content creator Sherlyn Chopra, who was charged by the Mumbai Police’s cyber cell for uploading pornographic and obscene videos online. The Court directed the actor to cooperate with the investigation, report at the police station daily from March 15-17, and directed the police to report to it on the next date of hearing, which is March 23. In this post, I use this case to comment

Sherlyn Chopra Case: Non-Consensual Sharing of Intimate Images/Videos, Obscenity Laws and Copyright Remedies Read More »

SpicyIP Weekly Review (March 8 – 14)

/ By / Copyright, Patent, Trademark

Topical Highlight The Third to Tango: After Pakistan, Nepal Opposes India’s GI Application for Basmati In this post, Praharsh discusses the implications of Nepal joining Pakistan’s opposition to India’s application for registration of GI over Basmati in the EU. He noted that this could be the first IP dispute between the three South Asian countries.  He highlighted three major reasons reported for Nepal’s opposition: 1) Basmati is grown and consumed traditionally in Nepal; 2) Nepal has worked extensively with national and international

SpicyIP Weekly Review (March 8 – 14) Read More »

BigBasket and Daily Basket Row – Confusion or Bullying?

/ By / Trademark

As widely reported in the media, and shared via social media posts, the legal team of BigBasket sent a ‘cease and desist letter’ to Daily Basket on 17th February, 2021 alleging infringement of their trademark. The disparity in the sizes of both the companies was immediately evident to everyone: BigBasket by its own admission is the largest online food and grocery store in India whereas Daily Basket claims to be a tiny bootstrapped Coimbatore-based two-person start-up. Daily Basket is an

BigBasket and Daily Basket Row – Confusion or Bullying? Read More »

SpicyIP Weekly Review (February 15 – 21)

/ By / Copyright, Others, Patent, Trademark

Topical Highlight Justice Prabha Sridevan on Govt’s Proposal to Shut Down IPAB and the Way Forward In this guest post,  Justice (Retd.) Prabha Sridevan notes that the Government’s proposal to scrap the IPAB is a welcome change. She argues that the functioning of the IPAB makes the two ostensible reasons for tribunalisation unsustainable: expert insight and speedy justice. She argues that regular courts are also more than capable of eliciting expert opinions, citing multiple cases where this has been done. Further,

SpicyIP Weekly Review (February 15 – 21) Read More »

Revised Non-Personal Data Governance Framework and Intellectual Property Implications – Part II

/ By / Competition Law, Copyright, Privacy, Trade Secret

In Part I of this post, I highlighted the possible copyright and trade secret protection over the data mandated to be shared under the Revised Non-Personal Data (NPD) Governance Framework (the Report/Revised Report), and how the Report either overlooks or misunderstands these possible IP protections. In this part, I discuss the shortcomings in the Revised Report’s justifications for overriding IP protection and other rights over NPD. I also briefly explore alternatives to the Report’s heavy-handed regulatory architecture by turning to

Revised Non-Personal Data Governance Framework and Intellectual Property Implications – Part II Read More »

Revised Non-Personal Data Governance Framework and Intellectual Property Implications – Part I

/ By / Competition Law, Copyright, Data Exclusivity, Privacy, Trade Secret

The Committee of Experts on Non-Personal Data (NPD) Governance Framework headed by Kris Gopalakrishnan, constituted by the Ministry of Electronics and Information Technology had released its first Report in July, 2020. I had written about the Report for SpicyIP here. In December last year, a revised Report (“the Report/Revised Report” hereinafter) was released by the Committee with the goal of unlocking economic benefit from non-personal data, creating a data sharing framework, establishing community-based rights over NPD and addressing potential harms to privacy

Revised Non-Personal Data Governance Framework and Intellectual Property Implications – Part I Read More »

Scroll to Top